Effect of angiotensin-converting enzyme-inhibiting therapy on the expression of vascular endothelial growth factor in hyperstimulated rat ovary

Fertility and Sterility

Volumn 82, Issue SUPPL. 3, 2004, Pages 1127-1132

  Ozcakir, Hasan Tayfun ^a,b   Giray, Seren Gulsen ^a   Ozbilgin, Mahmut Kemal ^a   Inceboz, Umit Sungurtekin ^a   Caglar, Husnu ^a  

^a Celal Bayar Universitesi Hastanesi   (Turkey)

^b D53 Mavisehir Izmir TR 35540 T ^*  (Turkey)

Author keywords

ACE inhibitors; immunohistochemistry; OHSS; rat; renin angiotensin system; VEGF

Indexed keywords

ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GONADOTROPIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; FEMALE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NONHUMAN; OVARY DISEASE; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; FEMALE; IMMUNOHISTOCHEMISTRY; OVARIAN HYPERSTIMULATION SYNDROME; OVARY; RATS; RATS, WISTAR; STAINING AND LABELING; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 5044240455     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2004.03.053     Document Type: Article

References (29)

1. H.F. Dvorak, L.F. Brown, M. Detmar, A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1995 1029 1039
2. B.R. Kamat, L.F. Brown, E.J. Manseau, D.R. Senger, H.F. Dvorak Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells Am J Pathol 146 1995 157 165
3. Y. Abramow, V. Barak, B. Nisman, J. Schenker Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome Fertil Steril 67 1997 261 265
4. N. McClure, D.L. Healy, P.A. Rogers, J. Sullivan, L. Beaton, R.V. Haning Jr Vascular endothelial growth factor as a capillary permeability factor in ovarian hyperstimulation syndrome Lancet 344 1994 235 236
5. J. Neulen, Z. Yan, S. Raczek, K. Weindel, C. Keck, H.A Weich Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome J Clin Endocrinol Metab 80 1995 1967 1971
6. R. Gomez, C. Simon, J. Remohi, A. Pellicer Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability Biol Reprod 68 2003 2164 2171
7. B. Williams, A.Q. Baker, B. Gallacher, D. Lodwick Angiotensin II increases vascular permeability factor gene expression by human vascular smooth cells Hypertension 25 1995 913 917
8. I.M. Hogeboom van Buggenum, B.C. Polak, J.W. Reichert-Thoen, W.A. Vries-Knoppert, V.W. van Hinsbergh, G.J. Tangelder Angiotensin-converting enzyme-inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy Diabetologia 45 2002 203 209
9. R. Gomez, C. Simon, J. Remohi, A. Pellicer Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade Endocrinology 143 2002 4339 4348
10. R. Agrawal, S.L. Tan, S. Wild, P. Sladkevicius, L. Engmann, N Payne Serum vascular endothelial growth factor concentrations in in-vivo fertilization cycles predict the risk of ovarian hyperstimulation syndrome Fertil Steril 71 1999 287 293
11. A. Lee, K.A. Burry, L.K. Christenson, P.E. Patton, R.L. Stouffer Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization Fertil Steril 68 1997 305 311
12. E.R. Levin, G.F. Rosen, D.L. Cassidenti, B. Yee, D. Meldrum, A Wisot Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome J Clin Invest 102 1998 1978 1985
13. H. Yarali, B.G. Fleige-Zahradka, B. Ho Yuen, F. McComb The ascites in the ovarian hyperstimulation syndrome does not originate from the ovary Fertil Steril 59 1993 657 661
14. J.S. Krasnow, S.L. Berga, D.S. Guzick, A.J. Zeleznik, K.T. Yeo Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report Fertil Steril 65 1996 552 555
15. B. McElhinney, J. Ardill, C. Caldwell, F. Lloyd, N. McClure Variations in serum vascular endothelial growth factor binding profiles and the developments of ovarian hyperstimulation syndrome Fertil Steril 78 2002 286 290
16. B. McElhinney, J. Ardill, C. Caldwell, N. McClure Preventing ovarian hyperstimulation by inhibiting the effects of vascular endothelial growth factor J Reprod Med 48 2003 243 246
17. T. Ohba, T. Ujioka, K. Ishikawa, N. Tanaka, H. Okamura Ovarian hyperstimulation syndrome-model rats; the manifestation and clinical implication Mol Cell Endocrinol 202 2003 47 52
18. J.L. Frederick, T. Shimanuki, G.S. DiZerega Initiation of angiogenesis by human follicular fluid Science 224 1984 389 390
19. N. Glorioso, S.A. Atlas, J.H. Laragh, R. Jewelewicz, J.E. Sealey Pro-renin in high concentrations in human ovarian follicular fluid Science 233 1986 1422 1424
20. J.E. Sealey, S.A. Atlas, N. Glorioso, H. Manapat, J.H. Laragh Cyclical secretion of pro-renin during the menstrual cycle: synchronization with luteinizing hormone and progesterone Proc Natl Acad Sci USA 82 1985 8705 8709
21. A.C. Ong, V. Eisen, D.P. Rennie, R. Homburg, G.C. Lachelin, H.S Jacobs The pathogenesis of the ovarian hyperstimulation syndrome (OHS): a possible role for ovarian renin Clin Endocrinol 34 1991 39 43
22. D. Navot, A. Relau, A. Birkenfeld, R. Rabinowitz, A. Brzezinski, E.J. Margalioth Risk factors and prognostic variables in the ovarian hyperstimulation syndrome Am J Obstet Gynecol 159 1988 210 215
23. W. Van de Vrie, M.G. Baggen, W. Visser, F.H. Derkx, B. Morrel, R.J. Ouwendijk High renin and pro-renin in plasma and pleural exudate of a patient with the ovarian hyperstimulation syndrome Neth J Med 6 1997 232 236
24. T.G. Gul, C. Posaci, S. Caliyiskan The role of enalapril in the prevention of ovarian hyperstimulation syndrome: a rabbit model Hum Reprod 16 2001 2253 2257
25. R.S. Morris, L.L. Wong, E. Kirkman, E. Gentschein, R.J. Paulson Inhibition of ovarian derived pro-renin to angiotensin cascade in the treatment of ovarian hyperstimulation syndrome Hum Reprod 10 1995 1355 1358
26. F.S. Shihab, W.M. Bennett, J. Isaac, H. Yi, T.F. Andoh Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity Kidney Int 62 2002 422 433
27. T. Shimizu, H. Okamoto, S. Chiba, Y. Matsui, T. Sugawa, M Akino VEGF-mediated angiogenesis is impaired by angiotensinogen type 1 receptor blockade in cardiomyopathic hamster hearts Cardiovasc Res 58 2003 203 212
28. L. Morbidelli, A. Parenti, L. Giavannelli, H.J. Granger, F. Ledda, M. Ziche B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects Br J Pharmacol 124 1998 1286 1292
29. C. Emanueli, M.B. Salis, T. Stacca, G. Pintus, R. Kirchmair, J.M Isner Targeting kinin B1 receptor for therapeutic neovascularization Circulation 105 2002 360 366